Søgning på udtrykket 'pseudomonas' giver 40 resultater
Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Antimicrobial Agents And Chemotherapy
11.04.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Science
5.04.2024
Science, Volume 384, Issue 6691, April 2024.
Antimicrobial Agents And Chemotherapy
3.04.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Virulence
3.04.2024
Volume 15, Issue 1, December 2024 .
Proceedings of the National Academy of Sciences
28.03.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 13, March 2024.
Clinical Infectious Diseases
21.03.2024
Antimicrobial Agents And Chemotherapy
13.03.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Antimicrobial Agents And Chemotherapy
13.03.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Journal of Infectious Diseases
6.03.2024
Abstract . Background . Pseudomonas aeruginosa is a multidrug-resistant pathogen causing recalcitrant pulmonary infections in people with cystic fibrosis (pwCF). Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have been developed that partially correct the defective chloride channel driving disease. Despite the many clinical benefits, studies in adults have demonstrated that while P. aeruginosa sputum load decreases, chronic infection persists. Here, we investigate how P. aeruginosa in…
Antimicrobial Agents And Chemotherapy
6.03.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
PLoS One Infectious Diseases
26.02.2024
…nal agroprotectants. Pythium ultimum is a soil borne oomycete plant pathogen with a broad taxonomic host range exceeding 300 plants. Cucumber seedlings exposed to P. ultimum 1 day after a protective inoculation with bacterial endophyte accession IALR1619 (Pseudomonas sp.) recorded 59% survival; with the control assessed at 18%. When the pathogen was added 5 days post endophyte inoculation, 74% of the seedlings treated survived, compared to 36% of the control, indicating a longer-term effect of IALR1619. Und…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection has become a major public health concern. The recommendations for monotherapy and combination therapy in the current guidelines lack sufficient evidence to support them. The primary objective of this study is to determine the effectiveness of anti-Infective combination therapy compared to monotherapy in achieving clinical success in patien…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection has become a major public health concern. The recommendations for monotherapy and combination therapy in the current guidelines lack sufficient evidence to support them. The primary objective of this study is to determine the effectiveness of anti-Infective combination therapy compared to monotherapy in achieving clinical success in patien…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection has become a major public health concern. The recommendations for monotherapy and combination therapy in the current guidelines lack sufficient evidence to support them. The primary objective of this study is to determine the effectiveness of anti-Infective combination therapy compared to monotherapy in achieving clinical success in patien…
Infection and Immunity
23.02.2024
Infection and Immunity, Ahead of Print.
Infection and Immunity
23.02.2024
Infection and Immunity, Ahead of Print.
Virulence
21.02.2024
Volume 15, Issue 1, December 2024 .
Journal of Infectious Diseases
20.02.2024
… in vivo against Gram-negative pathogens important in human infections.Methods . MICs and bactericidal activity were determined using standard methods. An in vivo proof-of-concept efficacy study was conducted using a rabbit acute pneumonia model caused by Pseudomonas aeruginosa.Results . CF-370 exhibited potent antimicrobial activity, with MIC50/90 values (in µg/mL) for: P. aeruginosa, 1/2; Acinetobacter baumannii, 1/1; Escherichia coli, 0.25/1; Klebsiella pneumoniae, 2/4; Enterobacter cloacae 1/4; and Ste…
BMC Infectious Diseases
17.02.2024
. Abstract. . Aims. We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. . . . Methods and results. Umonium38 was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%,…
BMC Infectious Diseases
16.02.2024
. Abstract. . Aims. We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. . . . Methods and results. Umonium38 was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%,…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Morbidity and Mortality Weekly Report (MMWR)
19.01.2024
This report describes an outbreak of Pseudomonas infections associated with swimming in a hotel pool.
Morbidity and Mortality Weekly Report (MMWR)
4.08.2023
This report describes an investigation of two cases of carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa among ICU patients who stayed in the same hospital room.
ProMED
6.04.2023
P. aeruginosa -- United StatesFederal inspectors found dozens of issues at an eye drops manufacturer now linked to a fatal outbreak of drug-resistant bacteria, inspection records released by the Food and Drug Administration show, ranging from dirty equipment and clothing to missing safeguards and procedures.The FDA's findings were detailed in citations issued to Indian manufacturer Global Pharma Healthcare Pvt Ltd after an inspection from 20 Feb through 2 Mar 2023. This appears to have been the company's 1s…
ProMED
18.03.2023
P. aeruginosa -- United States'As of 14 Mar 2023, CDC, in partnership with state and local health departments, identified 68 patients in 16 states (CA, CO, CT, FL, IL, NC, NJ, NM, NY, NV, PA, SD, TX, UT, WA, WI) with VIM-GES-CRPA, a rare strain of extensively drug-resistant _P. aeruginosa_. Thirty-seven patients were linked to 4 healthcare facility clusters. One person has died and there have been 8 reports of vision loss and 4 reports of enucleation (surgical removal of eyeball). Dates of specimen collecti…
ProMED
8.02.2023
…nosa -- United StatesThe Food and Drug Administration (FDA) has warned against using 'Artificial Tears' eye drops produced by a Tamil Nadu-based firm after an outbreak of drug-resistant infections was linked to the drug in the USA. This is the 3rd such controversy involving an Indian pharma company.Another controversy has hit India's pharmaceutical industry as the United States warned that an eye drop manufactured by a Tamil Nadu-based firm has caused an outbreak of the drug-resistant bacterium _Pseudomonas
ProMED
4.02.2023
P. aeruginosa -- United StatesPatients should stop using EzriCare Artificial Tears pending additional information and guidance from CDC and FDA. If patients were advised to use EzriCare Artificial Tears by their healthcare provider, they should follow up with their healthcare provider for recommendations about alternative treatment options. Patients who have used EzriCare preservative-free artificial tears and who have signs or symptoms of an eye infection should seek medical care immediately. At this time,…
ProMED
2.02.2023
P. aeruginosa -- United StatesOne person has died and at least 3 others are left with permanent vision loss because of a bacterial infection possibly linked to a brand of over-the-counter eyedrops, according to the Centers for Disease Control and Prevention (CDC). A majority of those affected reported using preservative-free EzriCare Artificial Tears before becoming ill, CDC reported in a statement dated 20 Jan 2023. While the infections have not been definitively traced to the eyedrops, CDC recommended tha…
ProMED
8.05.2022
Hospital-Related Infection -- Norway
Eurosurveillance latest updates
5.05.2022
In November 2021, a clonal outbreak of Pseudomonas aeruginosa of novel sequence type ST3875 was detected in three patients who died of bloodstream infections in one hospital. By 25 April 2022, the outbreak included 339 cases from 38 hospitals across Norway. Initial hospital reports indicate Pseudomonas infection as the main contributing cause in seven deaths. In March 2022, the outbreak strain was identified in non-sterile pre-moistened disposable washcloths, used to clean patients, from three lots from the…
ProMED
19.04.2022
P. aeruginosa -- Bangladesh
Morbidity and Mortality Weekly Report (MMWR)
23.05.2019
Verona integron-encoded metallo-β-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa and other carbapenemase-producing organisms represent an emerging U.S. public health threat.
Morbidity and Mortality Weekly Report (MMWR)
31.05.2018
Eurosurveillance latest updates
5.05.2022
In November 2021, a clonal outbreak of Pseudomonas aeruginosa of novel sequence type ST3875 was detected in three patients who died of bloodstream infections in one hospital. By 25 April 2022, the outbreak included 339 cases from 38 hospitals across Norway. Initial hospital reports indicate Pseudomonas infection as the main contributing cause in seven deaths. In March 2022, the outbreak strain was identified in non-sterile pre-moistened disposable washcloths, used to clean patients, from three lots from the…
Morbidity and Mortality Weekly Report (MMWR)
19.01.2024
This report describes an outbreak of Pseudomonas infections associated with swimming in a hotel pool.
Eurosurveillance latest updates
15.12.2023
…drug-resistant Pseudomonas aeruginosa during interwaves. Additionally, during the first three waves, we observed significantly higher proportions and rates of cultures with Enterococcus faecium (pooled 10% vs 6% and 240 vs 120 per 10,000 admissions) and coagulase-negative Staphylococci (pooled 21% vs 14% and 500 vs 252 per 10,000 admissions) compared with pre-COVID-19. . . Conclusion. We observed no substantial changes in HRMO prevalence in hospitalised patients during the COVID-19 pandemic. . . .
Eurosurveillance latest updates
29.09.2023
…ion were described, with a focus on social determinants of health (SDoH). . . Methods. New cases during the study period of HAIs caused by extended-spectrum β-lactamase (ESBL)-/carbapenemase-producing Enterobacterales, MDR Acinectobacter baumannii, MDR Pseudomonas aeruginosa or meticillin resistant Staphylococcus aureus were considered. Among others, notification variables included sex and age, while socio-economic variables comprised several SDoH. Cases’ spatial distribution across municipalities was …
Morbidity and Mortality Weekly Report (MMWR)
4.08.2023
This report describes an investigation of two cases of carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa among ICU patients who stayed in the same hospital room.
ECDC COVID-19 updates
27.05.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
ECDC Communicable Disease Threats Report
26.05.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
Eurosurveillance latest updates
19.05.2023
. Background. Antimicrobial resistance (AMR) is of public health concern worldwide. . . Aim. We aimed to summarise the German AMR situation for clinicians and microbiologists. . . Methods. We conducted a systematic review and meta-analysis of 60 published studies and data from the German Antibiotic-Resistance-Surveillance (ARS). Primary outcomes were AMR proportions in bacterial isolates from infected patients in Germany (2016–2021) and the case fatality rates (2010–2021). Random and fixed (common) …